Pulsenmore

Company Overview

Snapshot

Founded in October 2014 by Elazar Sonnenschein, Pulsenmore operates with 51–200 employees. The company has raised a total of $119.57M across 8 funding rounds from 6 investors. In January 2026, Pulsenmore commenced trading on Nasdaq, expanding the reach of its FDA-authorized home prenatal ultrasound devices in the U.S.

Business overview

Pulsenmore develops universally accessible home ultrasound devices for remote care, enabling patients to self-scan by connecting their smartphones to a handheld ultrasound cradle. The technology facilitates remote clinical assessment by healthcare providers, particularly for prenatal ultrasound monitoring of fetal well-being. The company's solutions aim to enhance care availability, improve resource management, and increase patient satisfaction within the Health Tech & Life Sciences sector, specifically targeting medical devices, digital healthcare, and patient remote monitoring markets.

Strategic signal

In August 2026, Pulsenmore was selected for an Israel Innovation Authority and Ministry of Health program to lead a $1 million AI development project. This signifies a strategic move towards integrating advanced AI into its connected home ultrasound technology, indicating a focus on innovation and expanding its technological capabilities beyond current offerings. This development suggests a potential for enhanced diagnostic accuracy and efficiency in remote healthcare, positioning Pulsenmore for future growth in AI-driven medical solutions.

Company Intelligence Q&A

What was a significant recent strategic partnership for Pulsenmore?

In June 2026, Pulsenmore announced a strategic partnership with Ouma Health to expand access to remote prenatal care across the United States.

When did Pulsenmore receive FDA marketing authorization for its home-use prenatal ultrasound?

Pulsenmore received FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound in November 2025, pioneering a new era of prenatal care in the U.S.

What was a key commercial leadership appointment for Pulsenmore?

In June 2024, Pulsenmore appointed Len Farris as.

What was a notable expansion of Pulsenmore's partnership with Clalit Health Services?

In October 2024, Pulsenmore expanded its partnership with Clalit Health Services to deliver 25,000 home ultrasound devices for remote prenatal care.

What was a recent grant received by Pulsenmore?

In August 2026, Pulsenmore received a grant from the Israel Innovation Authority for its SmartScan AI program.